| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.04▼ | 1.03▲ | 1.04▼ | 1.08▼ | 1.22▼ |
| MA10 | 1.03▲ | 1.04▼ | 1.03▲ | 1.10▼ | 1.42▼ |
| MA20 | 1.03▲ | 1.03▲ | 1.05▼ | 1.23▼ | 1.53▼ |
| MA50 | 1.04▼ | 1.08▼ | 1.09▼ | 1.45▼ | 1.72▼ |
| MA100 | 1.08▼ | 1.11▼ | 1.21▼ | 1.55▼ | 2.13▼ |
| MA200 | 1.12▼ | 1.25▼ | 1.37▼ | 1.67▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.004▲ | 0.003▲ | -0.012▼ | -0.044▼ |
| RSI | 48.920▼ | 45.891▼ | 43.418▼ | 32.733▼ | 32.629▼ |
| STOCH | 54.167 | 34.849 | 63.100 | 19.081▼ | 8.843▼ |
| WILL %R | -50.000 | -40.053 | -50.056 | -89.165▼ | -94.330▼ |
| CCI | 65.977 | 1.530 | 1.820 | -92.311 | -178.365▼ |
|
Friday, November 14, 2025 06:41 AM
Can Bitcoin really overtake Nvidia's massive market cap in just five years? The simple math might surprise you.
|
|
Monday, October 27, 2025 03:46 AM
First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ...
|
|
Sunday, October 26, 2025 05:00 PM
CHICAGO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.02 | 1.07 | 1.00 | 1.04 | 179,295 |
| 13/11/25 | 1.07 | 1.0926 | 0.9841 | 1.01 | 214,687 |
| 12/11/25 | 1.13 | 1.15 | 1.06 | 1.07 | 188,953 |
| 11/11/25 | 1.14 | 1.16 | 1.09 | 1.12 | 165,632 |
| 10/11/25 | 1.13 | 1.15 | 1.10 | 1.15 | 128,349 |
| 07/11/25 | 1.08 | 1.13 | 1.05 | 1.12 | 260,082 |
| 06/11/25 | 1.12 | 1.14 | 1.08 | 1.10 | 208,067 |
| 05/11/25 | 1.07 | 1.15 | 1.0501 | 1.13 | 184,921 |
| 04/11/25 | 1.16 | 1.16 | 1.09 | 1.10 | 267,932 |
| 03/11/25 | 1.23 | 1.23 | 1.12 | 1.16 | 338,391 |
|
|
||||
|
|
||||
|
|